ProShare Advisors’s Larimar Therapeutics LRMR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$52.7K	Sell	11,700 -923	-7%	-$3.69K	﹤0.01%	1778
2025 Q4	$48.1K	Buy	12,623 +1,535	+14%	+$5.97K	﹤0.01%	1959
2025 Q3	$35.8K	Buy	11,088 +18	+0.2%	+$67	﹤0.01%	1959
2025 Q2	$32K	Sell	11,070 -915	-8%	-$2.12K	﹤0.01%	2036
2025 Q1	$25.8K	Sell	11,985 -2,885	-19%	-$9.12K	﹤0.01%	2019
2024 Q4	$57.5K	Buy	+14,870	New	+$98.2K	﹤0.01%	2161
2019 Q4	–	Sell	-843	Closed	-$7K	–	1795
2019 Q3	$7K	Sell	843 -334	-28%	-$3.66K	﹤0.01%	1655
2019 Q2	$17K	Sell	1,177 -143	-11%	-$3.81K	﹤0.01%	1613
2019 Q1	$43K	Buy	1,320 +11	+0.8%	+$564	﹤0.01%	1619
2018 Q4	$78K	Buy	+1,309	New	+$129K	﹤0.01%	1500
2016 Q4	–	Sell	-1,624	Closed	-$65K	–	1747
2016 Q3	$65K	Sell	1,624 -301	-16%	-$13.7K	﹤0.01%	1433
2016 Q2	$138K	Buy	1,925 +90	+5%	+$7.11K	﹤0.01%	1488
2016 Q1	$147K	Sell	1,835 -190	-9%	-$15K	﹤0.01%	1472
2015 Q4	$153K	Buy	2,025 +170	+9%	+$27.3K	﹤0.01%	1596
2015 Q3	$711K	Sell	1,855 -109	-6%	-$49.1K	0.01%	793
2015 Q2	$816K	Buy	1,964 +81	+4%	+$33.9K	0.01%	863
2015 Q1	$895K	Buy	1,883 +507	+37%	+$241K	0.01%	894
2014 Q4	$509K	Buy	+1,376	New	+$355K	0.01%	1190